Point Therapeutics Inc
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Point Therapeutics Inc - overview
Established
1993
Location
-, MA-Massachusetts, US
Primary Industry
Biotechnology
About
Point Therapeutics is a privately held biotechnology company focusing on developing therapeutics for the treatment of cancer and hematopoietic disorders.
Current Investors
Claflin Capital Management, DFJ Portage Venture Partners
Primary Industry
Biotechnology
Sub Industries
Biotechnology, Epidemiology
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Point Therapeutics Inc - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | Point Therapeutics Inc | - | ||||||||
| Trade Sale | Completed | Point Therapeutics Inc | - | ||||||||
| Unspecified Round | Completed | Point Therapeutics Inc | - | ||||||||
| Series B | Completed | Point Therapeutics Inc | - | ||||||||
| Unspecified Round | Completed | Point Therapeutics Inc | - |
Displaying 1 - 5 of 5
Point Therapeutics Inc - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.